An expert discusses how home administration of oncology drugs in the US faces significant logistical and reimbursement ...

Sarepta continues to work with regulators to complete the safety label update for Elevidys, and they are discussing an approach for risk mitigation for non-ambulatory patients.

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

In a press release in advance of an 8 a.m. earnings call, the company said that the second-quarter consolidated medical-care ratio of 89.4% increased 430 basis points year-over-year. The increase was ...

Medicare Advantage enrollment transforms post-acute care, impacting home health, hospice and skilled nursing services amid evolving value-based care challenges.

Jeremiah Johnson, executive director of PrEP4All, an organization committed to HIV prevention and care, talks about the ...

An expert discusses how integrating newer NMIBC therapies faces operational barriers including administration logistics, staff training and formulary restrictions, while solutions require better ...

Replimune's RP1 treatment for advanced melanoma faces FDA rejection due to trial design issues, despite promising results ...

Rising Medicare exit rates among physicians, especially primary care, highlight growing dissatisfaction and administrative ...

In this interview, Sarah Morris, chief product officer of Audere, explains why they chose to focus on women and young girls ...

The FDA has accepted the resubmitted BLA for tabelecleucel (tab-cel), intended for the treatment of Epstein-Barr virus ...

Two PBMs, True Rx Health Strategies and Capital Rx, are using pharmacogenomics — how a person’s DNA affects their response to ...